Literature DB >> 1938556

Interstitial brachytherapy: past-present-future.

C H Paine1, D V Ash.   

Abstract

This article summarizes and reviews the development of brachytherapy from 1930 to 1990. Its purpose is to highlight the immense contribution made to its underlying science and clinical practice by Dr. Frank Ellis, who has been personally involved with it, in theory and in practice, for that whole half-century. A remarkable achievement in itself, but so much the more when it is seen beside his contributions to other aspects of radiation in the service of man. The early use of solid sources leads on to a discussion of manual afterloading and iridium. This leads on to a quick survey of the development of dosimetry. Thereafter clinical indications are briefly discussed and some published results tabulated. Lastly, some pointers to possible future development and benefits are discussed. Mention is also made of some continuing unresolved problems where new work could help to establish the most appropriate use of brachytherapy.

Entities:  

Mesh:

Year:  1991        PMID: 1938556     DOI: 10.1016/0360-3016(91)90322-u

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Wound complications after resection and immediate postoperative brachytherapy in the management of soft-tissue sarcomas.

Authors:  R R Dalton; R M Lanciano; J P Hoffman; B L Eisenberg
Journal:  Ann Surg Oncol       Date:  1996-01       Impact factor: 5.344

2.  Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation.

Authors:  N A Janjan; A W Yasko; G P Reece; M J Miller; J A Murray; M I Ross; M M Romsdahl; M J Oswald; T G Ochran; R E Pollock
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

Review 3.  Modern head and neck brachytherapy: from radium towards intensity modulated interventional brachytherapy.

Authors:  György Kovács
Journal:  J Contemp Brachytherapy       Date:  2014-12-31

4.  Clinical outcome of high-dose-rate interstitial brachytherapy in patients with oral cavity cancer.

Authors:  Sung Uk Lee; Kwan Ho Cho; Sung Ho Moon; Sung Weon Choi; Joo Yong Park; Tak Yun; Sang Hyun Lee; Young Kyung Lim; Chi Young Jeong
Journal:  Radiat Oncol J       Date:  2014-12-30

5.  Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma.

Authors:  D Schnapauff; F Collettini; I Steffen; G Wieners; B Hamm; B Gebauer; M H Maurer
Journal:  Radiat Oncol       Date:  2016-02-25       Impact factor: 3.481

6.  High-dose-rate interstitial brachytherapy in head and neck cancer: do we need a look back into a forgotten art - a single institute experience.

Authors:  Rajendra Bhalavat; Manish Chandra; Vibhay Pareek; Lalitha Nellore; Karishma George; P Nandakumar; Pratibha Bauskar
Journal:  J Contemp Brachytherapy       Date:  2017-04-13

Review 7.  High dose rate brachytherapy for oral cancer.

Authors:  Hideya Yamazaki; Ken Yoshida; Yasuo Yoshioka; Kimishige Shimizutani; Souhei Furukawa; Masahiko Koizumi; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2012-11-23       Impact factor: 2.724

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.